Claus Andersson is a seasoned institutional investor in life sciences, serving as a General Partner at Sunstone Life Science Ventures since 2005. They are actively involved on the Board of Directors for multiple companies, including Rewind Therapeutics and DiogenX, as well as having previously held board positions with notable organizations such as Cantargia AB and Santaris Pharma. Their extensive experience includes advising the European Commission on risk financing and holding academic roles, including an Associate Professorship at the University of Copenhagen. Claus has a strong focus on developing pharmaceutical innovations, with a history of facilitating acquisitions and financial growth within the life sciences sector.
This person is not in the org chart
This person is not in any teams
This person is not in any offices